Skip to content
Proffi

ONCOSYNE AS

Org. no. 926 191 942 · Private limited company (AS) · Active · Ullernchausséen 64, 0379, OSLO · OSLO · 72.100 – Research and experimental development on natural sciences and engineering

ActiveVAT registeredRegister of Business Enterprises
Organisation form
AS
Employees
5
Established
30 November 2020
Municipality
OSLO
Industry code
72.100

ONCOSYNE AS is a private limited company (as) registered in OSLO since 2020. The organisation number is 926 191 942. The register lists 5 employees. The latest submitted annual accounts are for 2025.

Source: The Brønnøysund Register Centre · Last updated 22 November 2026 at 01:36

Overview

Quick overview

Status and key figures

Based on the latest submitted annual accounts (2025) and registry data.

Liquidity

Strong

7.88

How the figure is assessed

Current assets divided by current liabilities. Below 1.0 is weak, 1.0–1.5 needs attention and 1.5 or more is strong.

Profitability

Weak

-74 %

How the figure is assessed

Operating profit divided by operating revenue. Below 0% is weak, 0–10% needs attention and 10% or more is strong.

Solidity

Strong

88.1 %

How the figure is assessed

Equity divided by assets. Below 10% is weak, 10–30% needs attention and 30% or more is strong.

Operating revenue
4.2 m NOK
-3.6 % vs. the year before
Net result
-2.8 m NOK
Fiscal year 2025
Equity
8.0 m NOK
Fiscal year 2025
Status
Active
Central Coordinating Register
Employees
5
Registered in the Central Coordinating Register
Founded
30 November 2020
Place
OSLO
Industry
Research and experimental development on natural sciences and engineering
72.100
Public contracts
–
Roles
6
People and entities
The gauges are calculated key figures with open thresholds, not a credit assessment. All amounts come from the Register of Company Accounts.

Calculated by us

Proffi Risk Indicator

Low risk

Based on status, solvency, liquidity, profitability, trend and how recent the accounts are. Public register data only.

This is an indicative assessment, not a credit rating. It does not replace your own due diligence before entering into an agreement.

Proffi+

Proffi estimated value

Calculating …

Indicative model estimate based on public accounting figures and typical industry multiples. Not an appraisal, a valuation or investment advice.

Development

Revenue and profit

RevenueResult

Development

Solvency and profitability (%)

SolidityProfitability

Registry data

Company information

Organisation number
926 191 942
Organisation form
Private limited company (AS)
Registered in the Central Coordinating Register
16 December 2020
Date of incorporation
30 November 2020
Number of employees
5
Language form
Norwegian Bokmål
Latest submitted annual accounts
2025
Deleted
Not provided
Website
Not stated
Bankruptcy date
Not provided

Addresses

Visiting and postal address

Business address

Ullernchausséen 640379 OSLOOSLO municipalityNorge

Postal address

c/o Oslo Cancer Cluster Incubator, Ullernchausséen 640379 OSLOOSLO municipalityNorge
Show on map

Industry

Industry and sector

  • 72.100

    Research and experimental development on natural sciences and engineering(main industry)

    N Professional, scientific and technical activities › 72 Scientific research and development › 72.1 Research and experimental development on natural sciences and engineering › 72.10 Research and experimental development on natural sciences and engineering

    See the industry: largest companies and key figures →
    What does this industry cover?

    Omfatter: Forskning og eksperimentell utvikling innenfor naturvitenskap og teknikk; forskning og utvikling innenfor naturvitenskap, forskning og utvikling innenfor teknikk og teknologi, forskning og utvikling innenfor medisin, helse og veterinærvitenskap, forskning og utvikling innenfor bioteknologi, forskning og utvikling innenfor jordbruk, skogbruk og fiske, tverrfaglig forskning og utvikling, hovedsakelig innenfor naturvitenskap og teknikk. Omfatter også: DNA-sekvensering når formålet er generell forskning på biologiske prosesser. Ekskluderer: DNA-sekvensering for å utelukke eller kurere en spesifikk sykdom grupperes under 86.91 Medisinske laboratorietjenester og bildediagnostikk.

Institutional sector code: Private aksjeselskaper mv. (2100)

Statutory purpose

Forskning og utviklingsarbeid innen medisinsk bioteknologi med det formål å tilby legemiddelscreening som en diagnostisk tjeneste. Legemiddelscreenen skal være et beslutningsverktøy for skånsom, presis og effektiv kreftbehandling.

Registry status

Registrations and status

  • Registered in the Register of Business Enterprises
  • Registered in the VAT register
  • Registered in the Register of Non-Profit Organisations
  • Registered in the Register of Foundations
  • Bankruptcy
  • In liquidation
  • In compulsory liquidation

Experiences

Reviews

Loading reviews …

Write a review

You must sign in with a verified email to write a review.

Accounts

Financial overview

Accounts and key figures

Fiscal year 2025 · Amounts in NOK

Data basis

3 stored years

Liquidity

Strong

7.88

How the figure is assessed

Current assets divided by current liabilities. Below 1.0 is weak, 1.0–1.5 needs attention and 1.5 or more is strong.

Profitability

Weak

-74 %

How the figure is assessed

Operating profit divided by operating revenue. Below 0% is weak, 0–10% needs attention and 10% or more is strong.

Solidity

Strong

88.1 %

How the figure is assessed

Equity divided by assets. Below 10% is weak, 10–30% needs attention and 30% or more is strong.

Key numbers and development

Only reported amounts from the Register of Company Accounts

Accounting item202520242023Development
Operating revenue4,221,3114,379,9801,656,989
Operating profit-3,122,620-1,981,054-3,186,683
Profit before tax-2,803,869-1,721,316-3,140,780
Net result-2,803,869-1,721,316-3,140,780
Total assets9,033,69811,963,8585,802,910
Equity7,957,91310,761,7825,197,039
Liabilities1,075,7841,202,076605,872
The gauges are calculated key figures with open thresholds. They are not a credit assessment.

Graphical analysis

3 fiscal years (2023–2025)

Operating revenue 2025
4,221,311 NOK
Net result 2025
-2,803,869 NOK
Revenue growth
-3.6 %

Revenue and profit

Amounts in NOK

Operating margin

Calculated by us, in percent

Equity and liabilities

Balance sheet in NOK

Register of Company Accounts

Annual accounts 2025

Period 2025-01-01 to 2025-12-31. Currency NOK. Audited annual accounts. Virksomheten har fravalgt revisjon.

Income statement

Total operating revenue4,221,311 NOK
Total operating expenses7,343,931 NOK
Operating profit-3,122,620 NOK
Total financial income330,169 NOK
Total financial expenses11,418 NOK
Net financial items318,751 NOK
Profit before tax-2,803,869 NOK
Net result-2,803,869 NOK

Assets

Total fixed assets553,297 NOK
Total current assets8,480,400 NOK
Total assets9,033,698 NOK

Equity and liabilities

Paid-in equity17,100,461 NOK
Retained earnings-9,142,547 NOK
Total equity7,957,913 NOK
Current liabilities1,075,784 NOK
Total debt1,075,784 NOK
Total equity and liabilities9,033,698 NOK

Register of Company Accounts

Annual accounts 2024

Period 2024-01-01 to 2024-12-31. Currency NOK. Audited annual accounts. Virksomheten har fravalgt revisjon.

Income statement

Total operating revenue4,379,980 NOK
Total operating expenses6,361,033 NOK
Operating profit-1,981,054 NOK
Total financial income278,638 NOK
Total financial expenses18,900 NOK
Net financial items259,738 NOK
Profit before tax-1,721,316 NOK
Net result-1,721,316 NOK

Assets

Total fixed assets856,717 NOK
Total current assets11,107,141 NOK
Total assets11,963,858 NOK

Equity and liabilities

Paid-in equity17,100,461 NOK
Retained earnings-6,338,679 NOK
Total equity10,761,782 NOK
Current liabilities1,202,076 NOK
Long-term liabilities0 NOK
Total debt1,202,076 NOK
Total equity and liabilities11,963,858 NOK

Register of Company Accounts

Annual accounts 2023

Period 2023-01-01 to 2023-12-31. Currency NOK. Audited annual accounts. Virksomheten har fravalgt revisjon.

Income statement

Total operating revenue1,656,989 NOK
Total operating expenses4,843,673 NOK
Operating profit-3,186,683 NOK
Total financial income65,665 NOK
Total financial expenses19,761 NOK
Net financial items45,903 NOK
Profit before tax-3,140,780 NOK
Net result-3,140,780 NOK

Assets

Total fixed assets84,859 NOK
Total current assets5,718,052 NOK
Total assets5,802,910 NOK

Equity and liabilities

Paid-in equity9,814,402 NOK
Retained earnings-4,617,363 NOK
Total equity5,197,039 NOK
Current liabilities605,872 NOK
Long-term liabilities0 NOK
Total debt605,872 NOK
Total equity and liabilities5,802,910 NOK

Source: Register of Company Accounts, Brønnøysund Register Centre. Figures are shown as submitted, and historical years are never overwritten by newer submissions.

Key figures

Calculated by us

Key figures

Key figures 202520242023
Revenue growthChange in total operating revenue from the previous fiscal year.-3.6 %164.3 %–
Operating marginOperating profit divided by total operating revenue.-74 %-45.2 %-192.3 %
Profit marginOrdinary profit before tax divided by total operating revenue.-66.4 %-39.3 %-189.5 %
Equity ratioTotal equity divided by total assets.88.1 %90 %89.6 %
Current ratioTotal current assets divided by total current liabilities.7.889.249.44
Debt ratioTotal liabilities divided by total equity.0.140.110.12
Return on assetsOrdinary profit before tax plus financial expenses, divided by total assets.-30.9 %-14.2 %-53.8 %
Return on equityNet profit divided by total equity.-35.2 %-16 %-60.4 %

About the calculation

The key figures are calculated by us (formula version v1) from public accounts in the Register of Company Accounts. A figure is only calculated when all input values exist and the denominator is not zero. The figures are not a credit assessment.

Roles and owners

Registry data

Roles

Board

Accountant

Source: The Brønnøysund Register Centre. We only show name and role as published by the register – never date of birth or private address.

Organisation

Structure

Organisation structure

Entity type
Main entity
Parent entity
Not stated
Number of sub-units
1

Overview

Structure map

ONCOSYNE AS
  • ONCOSYNE AS

    OSLO · 5 employees

Registry data

Sub-units

NameOrg. no.PlaceEmployees
ONCOSYNE ASResearch and experimental development on natural sciences and engineering926 284 622OSLO5

More about the company

This has not been registered yet. We never show made-up information.

  • Services and products

    The company has not added any services yet.

  • Public approvals

    Not in the Norwegian Building Authority's central approval register.

  • Public contracts

    No notices found in TED where the company is a supplier or contracting authority.

  • Registered changes

    We show changes from the Brønnøysund Register Centre's change log from the next registered change.

  • Documents

    Certificates of registration and other documents require a separate agreement with a document provider.

Claim the profile and add services

Transparency

Sources and data quality

  • Company information

    Brønnøysund Register Centre · Public register

    Last retrieved 22 November 2026 at 01:37

    Open official source
  • Roles

    Brønnøysund Register Centre · Public register

    Last retrieved 22 November 2026 at 01:37

    Open official source
  • Accounts and key figures

    Register of Company Accounts · Public register

    Last retrieved 22 November 2026 at 01:37

    Open official source
  • Address (verified)

    Norwegian Mapping Authority – Geonorge address API · Public register

    Last retrieved 22 November 2026 at 01:36

    Open official source
  • Central approval

    Norwegian Building Authority (DiBK) · No approval found

    Last retrieved 22 November 2026 at 01:37

    Open official source
  • Industry standard (SN2007)

    Statistics Norway – KLASS · Official standard

    Last retrieved 22 November 2026 at 01:37

    Open official source

Public registry data is updated periodically and cannot be changed by the company. Calculated figures are marked “Calculated by us”.

Report an error

Source

Public registry fields on this page come from the Central Coordinating Register and cannot be changed by the company. Self-reported content is marked separately.

Read about the data sources

Talk to Proffi

From company data to new customers – we show you how

Leave your contact details and an adviser will explain how segmentation, company profiles and supplier search can support your business.

Your contact details